该公司生化研发主任约什？克莱恩（JoshKlein）将其取代鸡蛋的策略比作药品公司可能用于对抗疾病的过程。
Josh Klein , its director of biochemistry RD , likens the company 's egg-replacing strategy to the process a drug company might use to fight disease .
取代策略